Report #2838890

Received Apr 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 70 yrs
State: MS
Recovered: Not recovered
Vaccinated: Apr 23, 2025
Onset: Apr 23, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	F95YS	IM / LA

Symptoms (1)

Eye swelling

Symptom narrative

Left eye Swollen; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of eye swelling in a 70-year-old female patient who received Herpes zoster (Shingrix) (batch number F95YS, expiry date 31-MAR-2027) for prophylaxis. On 23-APR-2025, the patient received the 1st dose of Shingrix (intramuscular, left deltoid). On 23-APR-2025, less than a day after receiving Shingrix, the patient experienced eye swelling (Verbatim: Left eye Swollen). The outcome of the eye swelling was not resolved. It was unknown if the reporter considered the eye swelling to be related to Shingrix. It was unknown if the company considered the eye swelling to be related to Shingrix. Additional Information: GSK receipt date: 23-APR-2025 The pharmacist called on behalf of the patient who had received her first Shingrix vaccine today in her left arm and came back 2 hours later same day with her swollen left eye.